ABC927MI

MilliporeSigma™ Rabbit anti-LDHB, Polyclonal,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 ABC927MI-Each-of-1 In Stock ₹ 42,968.31

ABC927MI - Each of 1

₹ 42,968.31

In Stock

Quantity

1

Base Price: ₹ 42,968.31

GST (18%): ₹ 7,734.296

Total Price: ₹ 50,702.606

Antigen

LDHB

Classification

Polyclonal

Gene Accession No.

P07195

Host Species

Rabbit

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Applications

Immunohistochemistry (Paraffin), Western Blot

Formulation

Purified rabbit polyclonal antibody in buffer containing 0.1M Tris-Glycine (pH 7.4), 150mM NaCl with 0.05% sodium azide.

Gene Symbols

LDHB

Immunogen

KLH-conjugated linear peptide corresponding to human LDHB sequence from the C-terminal half.

Quantity

100 μg

Research Discipline

Apoptosis, Cancer

Gene ID (Entrez)

NP_002291

Content And Storage

Stable for one year at 2°C to 8°C from date of receipt.

Related Products

Img

MilliporeSigma™

ABC924MI

--

Img

MilliporeSigma™

ABC937MI

--

Img

MilliporeSigma™

ABC926MI

--

Img

MilliporeSigma™

ABC970MI

--

Img

MilliporeSigma™

ABC925MI

--

Img

MilliporeSigma™

ABC490MI

--

Img

MilliporeSigma™

ABN1480MI

--

Img

MilliporeSigma™

ABF184MI

--

Description

  • Specifically detects LDHB in Human samples, and it is validated for Immunohistochemistry (Paraffin), Western Blotting L-lactate dehydrogenase B chain (EC 1.1.1.27; UniProt P07195; also known as Epididymis secretory protein Li 281, Lactate dehydrogenase H chain, LDH-B, LDH-H, LDH heart subunit, Renal carcinoma antigen NY-REN-46) is encoded by the LDHB (also known as LDHBD, TRG-5, HEL-S-281) gene (Gene ID 3945) in human
  • Originally described by Otto Warburg and now commonly known as the Warburg effect refers to the phenomenon that many tumor cells use aerobic glycolysis instead of mitochondrial respiration for energy production to support cell growth and proliferation
  • Enzymes involved in the complex network of metabolic pathways are therefore being studied as potential targets for cancer treatment
  • Lactate dehydrogenase (LDH) is a tetrameric enzyme composed of two different subunits, LDHA and LDHB, which can assemble into five different combinations (LDH1 is comprised of four LDHB subunits; LDH2 contains three LDHB and one LDHA subunit; LDH3 contains two LDHB and two LDHA subunits; LDH4 contains one LDHB and three LDHA subunits; LDH5 contains four LDHA subunits)
  • LDHB is ubiquitously expressed and the predominant isoform in heart muscle, while LDHA is the predominant isoform in skeletal muscle and other highly glycolytic tissues
  • LDH catalyzes the reversible conversion of pyruvate into lactate
  • An upregulation of LDH therefore reduces the oxygen dependency and ensures an efficient anaerobic/glycolytic metabolism in tumor cells
  • Serum LDHB levels, for example, are reported to elevate in lung cancer patients and progressively increase with the clinical stage of non-small cell lung cancer (NSCLC).